We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRIP icon
101
TripAdvisor
TRIP
$1.26B
$4.24M 0.24%
+213,481
New +$4.56M
SSL icon
102
Sasol
SSL
$7.38B
$4.04M 0.23%
+296,255
New +$4.6M
SPH icon
103
Suburban Propane Partners
SPH
$1.17B
$4M 0.23%
260,812
+5,706
+2% +$88.3K
KFY icon
104
Korn Ferry
KFY
$4.3B
$3.93M 0.22%
+75,936
New +$4.1M
GSM icon
105
FerroAtlántica
GSM
$865M
$3.77M 0.21%
762,239
+18,103
+2% +$83.6K
BV icon
106
BrightView Holdings
BV
$1.05B
$3.7M 0.21%
657,694
+246,578
+60% +$1.66M
VREX icon
107
Varex Imaging
VREX
$778M
$3.61M 0.2%
+198,429
New +$3.78M
UDMY
108
DELISTED
Udemy
UDMY
$3.53M 0.2%
+399,374
New +$4.21M
DSP icon
109
Viant Technology
DSP
$282M
$3.49M 0.2%
803,390
– –
QDEL icon
110
QuidelOrtho
QDEL
$943M
$3.45M 0.19%
38,724
+891
+2% +$77.5K
CGNT icon
111
Cognyte Software
CGNT
$689M
$3.12M 0.18%
919,102
+20,814
+2% +$75K
ALIT icon
112
Alight
ALIT
$394M
$3.09M 0.17%
+16,780
New +$3.08M
UPLD icon
113
Upland Software
UPLD
$14.5M
$2.86M 0.16%
66,400
+36,096
+119% +$2.5M
COUR icon
114
Coursera
COUR
$1.52B
$2.75M 0.16%
+239,010
New +$3.09M
HURC icon
115
Hurco Companies Inc
HURC
$141M
$2.69M 0.15%
106,437
+4,052
+4% +$112K
CASA
116
DELISTED
Casa Systems, Inc. Common Stock
CASA
$2.62M 0.15%
2,063,473
+41,385
+2% +$126K
ONTF
117
DELISTED
ON24
ONTF
$2.33M 0.13%
265,456
-75,199
-22% -$664K
HBB icon
118
Hamilton Beach Brands
HBB
$444M
$2.17M 0.12%
211,483
-92,997
-31% -$1.13M
FONR
119
DELISTED
Fonar
FONR
$2.13M 0.12%
131,530
+3,242
+3% +$56.1K
AMPL icon
120
Amplitude
AMPL
$1.52B
$2.1M 0.12%
+168,968
New +$2.24M
ECHO
121
EchoStar
ECHO
$25.9B
$2.09M 0.12%
+114,080
New +$2.09M
ABEV icon
122
Ambev
ABEV
$45.4B
$2.07M 0.12%
+734,890
New +$1.92M
PRSU
123
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$1.99M 0.11%
+95,534
New +$2.38M
CSTL icon
124
Castle Biosciences
CSTL
$988M
$1.98M 0.11%
+87,252
New +$2.13M
CSTE icon
125
Caesarstone
CSTE
$88.2M
$1.89M 0.11%
456,550
+10,583
+2% +$58.7K
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.